TORONTO, Canada (April 20, 2016) – Jon Ruiz, President and CEO of PharmaCielo Ltd., a global company privately held and headquartered in Canada with a focus on processing and supplying all natural, medicinal-grade cannabis oil extracts throughout the world, made the following statement today:
"On behalf of PharmaCielo Ltd. I commend Canada's Minister of Health, the Hon. Jane Philpott for representing the Government of Canada at the United Nations General Assembly Special Session on the World Drug Problem (UNGASS 2016) and for taking a prominent leadership role in the global effort to eradicate the cannabis black market.
“The Minister of Health's commitment to keep the profits from the cannabis market out of the hands of criminals and ending the black market in Canada has put the country at the forefront of this important international policy discussion.
“This legalization of cannabis is a complex endeavor and Canada's prime minister should be commended for demonstrating leadership on the eradication of the black market and working towards implementing a responsible plan to move forward.
“With countries around the world being ravaged by the drug war, it is time for leaders to take the necessary steps to end the prohibition of cannabis and open the door to examine the best practices to supply consumers with the safest, highest quality product at an accessible cost to the public.
“PharmaCielo Ltd. is committed to offering high-quality, medicinal-grade cannabis oil extracts, and we look forward to working with the Government of Canada during the ongoing consultation process."
About PharmaCielo Ltd.
PharmaCielo Ltd. is a global company privately held and headquartered in Canada. Wholly owned subsidiary PharmaCielo Colombia Holdings S.A.S maintains operations in Rionegro, Colombia and has applied for licences from the Colombian government with a focus on processing and supplying naturally grown and processed, standardized medicinal-grade cannabis oil extracts and related products to large channel distributors of standardized medical cannabis products, finished goods producers, research organizations and pharmaceutical companies.
The boards of directors and executive teams of PharmaCielo Ltd. and PharmaCielo Colombia are comprised of a diversely talented group of international business executives and specialists with the relevant expertise to ensure long-term success. The team recognized the significant role Colombia's ideal location would play in building a sustainable business in the medical cannabis industry and has built a strong business plan focused on supplying the international medical marketplace.
This press release contains forward-looking statements. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or “recurring” or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking statements involve known and unknown risks, uncertainties and other factors, such as demand for the Company’s products, currency exchange changes and risks, internal funding and the financial condition of the Company, product roll-out, competition, technological changes, and other commercial matters involving the Company, its products, and the markets in which the Company operates, as well as general economic conditions, which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Actual results and developments are likely to differ, and may differ materially, from those expressed or implied by the forward-looking statements contained in this press release. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.
Except as required by law, we undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. However, any further disclosures made on related subjects in subsequent reports should be consulted.